A population study of apoE genotype at the age of 85: Relation to dementia, cerebrovascular disease, and mortality

Journal of Neurology Neurosurgery and Psychiatry

Volumn 64, Issue 1, 1998, Pages 37-43

  Skoog, Ingmar ^a   Hesse, Camilla ^b   Aevarsson, Ólafur ^a   Landahl, Sten ^c   Wahlström, Jan ^c   Fredman, Pam ^b   Blennow, Kaj ^b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Institute of Clinical Neurosciences   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

apoE genotype; Cerebrovascular disorder; Dementia

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DEMENTIA; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; WHITE MATTER;

EID: 0031971434     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.64.1.37     Document Type: Article

References (54)

1. Corder EH, Saunders AM, Strittmatr WJ, Schmechel DE, Gaskell PC, Small GW, et al. Gene dose of apoliporotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-3.
2. Saunders AM, Schmader K, Breitner JC, Benson MD, Brown WT, Goldfarb L, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-1.
3. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
4. Poirier J, Davignon J, Bouthillier D, Kogan S, Bertrand P, Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet 1993;342:697-9.
5. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81.
6. Henderson AS, Easteal S, Jorm AF, Mackinnon AJ, Korten AE, Christensen H, et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet 1995;346:1387-90.
7. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer L, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ 1994;309:1202-5.
8. Kuusisto J, Koivisto K, Kervinen K, Mykkänen L, Helkala E-L, Vanhanen M, et al. Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ 1994;309:636-8.
9. Stengård JH, Pekkanen J, Sulkava R, Ehnholm C, Erkinjuntti T, Nissinen A. Apolipoprotein E polymorphism, Alzheimer's disease and vascular dementia among elderly Finnish men. Acta Neurol Scand 1995;92:297-8.
10. Myers RH, Schaefer EJ, Wilson PWF, D'Agostino R, Ordovas JM, Espino A, et al. Apolipoprotein E e4 association with dementia in a population-based study: the Framingham study. Neurology 1996;46:673-7.
11. Evans DA, Becket LA, Field TS, Feng L, Albert MS, Bennett DA, et al. Apolipoprotein E e4 and incidence of Alzheimer disease in a community population of older persons. JAMA 1997;277:822-4
12. Rebeck GW, Peris TT, West HL, Sodhi P, Lipsitz LA, Hyman BT. Reduced apolipoproteinen ε4 allele frequency in the oldest old. Alzheimer's patients and cognitively normal individuals. Neurology 1994;44:1513-6.
13. Corder E, Basun H, Lannfelt L, Viitanen M, Winblad B. Apolipoprotein E-E4 gene dose. Lancet 1995;346:967-8.
14. Sobel E, Louhija J, Sulkava R, Davanipour Z, Kontula K, Miettinen H, et al. Lack of association of apolipoprotein E allele ε4 with late-onset Alzheimer's disease among Finnish centenarians. Neurology 1995;45:903-7.
15. Skoog I. Blood pressure and dementia. In: Hansson L, Birkenhäger WH, eds. Handbook of hypertension. Vol 18. Assessment of hypertensive organ damage. Amsterdam: Elsevier, 1997:303-31.
16. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8: 1-21.
17. van Bockxmeer FM, Mamotte CDS. Apolipoprotein E4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-80.
18. Pedro-Botet J, Senti M, Nogués X, Rubiés-Prat J, Roquer J, D'Olhaberriague L, Olivé J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein (a), triglyceride-rich lipoproteins, and apoliprotein E polymorphism. Stroke 1992;23:1556-62.
19. Shimano H, Ishibashi S, Murase T, Gotohda T, Yamada N, Takaku F, Ohtomo E. Preliminary note: plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 1989;79:257-60.
20. Noguchi S, Murakami K, Yarnada N. Letters to the editor: apolipoprotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
21. Frisoni GB, Bianchetti A, Govoni S, Trabucchi M, Calabresi L, Franceschini G. Association of apolipoprotein E E4 with vascular dementia. JAMA 1994;271:1317.
22. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
23. Skoog I, Palmertz B, Andreasson L-A. The prevalence of white matter lesions on computed tomography of the brain in demented and non-demented 85-year-olds. J Geriatr Psychiatry Neurol 1994;7:169-75.
24. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-62.
25. de la Monte S. Quantitation of cerebral atrophy in preclinical and end-stage Alzheimer's disease. Ann Neurol 1989;25: 450-9.
26. Diaz FJ, Metskey H, Hachinski VC, Lee DH, Boniferro M, Wong CJ, et al. Improved recognition of leukoaraiosis and cognitive impairment in Alzheimer's disease. Arch Neurol 1991;48:1022-5.
27. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam study. Lancet 1997;349:151-4.
28. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, et al. A 15-year longitudinal study on blood pressure and dementia. Lancet 1996;347:1141-5.
29. Rinder L, Roupe S, Steen B, Svanborg A. Seventy-year-old people in Gothenburg. A population study in an industrialized Swedish city. I. General presentation of the study. Acta Med Scand 1975;198:397-407.
30. Skoog I, Nilsson L, Palmertz B, Andreasson L, Svanborg A. A population-based study of dementia in 85-year-olds. N Engl J Med 1993;328:153-8.
31. Aevarsson O, Skoog I. A population-based study on the incidence of dementia disorders between 85 and 88 years of age. J Am Geriatr Soc 1996;44:1455-60.
32. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 3rd ed, revised. Washington, DC: APA, 1987.
33. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group Under the Auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34: 939-44.
34. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatry 1988;51:1037-44.
35. Kane JW, Gowland G. A method for the identification of apolipoprotein E isoforms employing chemical precipitation and flat bed isoelectric focusing in agarose. Ann Clin Biochem 1986;23:509-13.
36. Cox DR, Hinkley DV. Theoritical statistics. London: Chapman and Hall, 1974.
37. Campbell MJ, Machin D. Medical statistics. A commonsense approach. Chichester: John Wiley, 1993:64-66.
38. Corder EH, Lannfelt L, Viitanen M, Corder LS, Manton KG, Winblad B, Basun H. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol 1996;53:418-22.
39. Blacker D, Haines JL, Rodes L, Terwedow H, Go RCP, Harrell LE, et al. ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative. Neurology 1997;48: 139-47.
40. Breitner JC. New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause. Neurobiol Aging 1994;15:175-7.
41. Tomlinson BE, Henderson G. Some quantitative cerebral findings in normal and demented old people. In: Terry RD, Gershon S, eds. Neurobiology of aging. New York: Raven Press, 1976:183-204.
42. Poirier J, Minnich A, Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Trends Mol Med 1995;27:663-70.
43. Jellinger K, Danielczyk W, Fischer P, Gabriel E. Clinicopathological analysis of dementia disorders in the elderly. J Neurol Sci 1990;95:239-58.
44. Wade JP, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-9.
45. Slooter AJ, Tang M-X, van Duijn CM, Stern Y, Ott A, Bell K, et al. Apolipoprotein E ε4 and the risk of dementia with stroke. A population-based investigation. JAMA 1997;277: 818-21.
46. Pirttila T, Lehtimaki T, Nikkari T, Frey H, Mattila K. Apolipoprotein E E4 allele and risk of dementia [letter]. JAMA 1995;272:373.
47. Landen M, Thorsell A, Wallin A, Blennow K. The apolipoprotein allele e4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1996;61: 352-6.
48. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 1994;7:180-3.
49. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of Apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993;24:661-664.
50. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, et al. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke 1996; 27:1310-5.
51. Polvikoski T, Sulkava R, Haltia M, Kainulainen K, Vuorio A, Verkkoniemi A, Niinisto L, et al. Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N Engl J Med 1995;333:1242-7.
52. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39: 2125-29.
53. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
54. Blennow K, Wallin A. Clinical heterogeneity of probable Alzheimer's disease. J Geriatr Psychiatry Neurol 1992;5: 106-13.